PFSA
Profusa, Inc.
NASDAQ · Healthcare · Medical - Equipment & Services · US
$0.90
−3.32%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- -87.7%
- EBIT
- —
- EPS
- +97.4%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- +70.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026